Page 114 - GPD-4-1
P. 114

Gene & Protein in Disease                                        Prognostic role of SIRT1 expression in cancer




                         A                                 B












                         C                                 D















                         E                                 F
















            Figure 3. Bubble plots analyzing various moderators of the studies. Our analysis showed no statistically significant heterogeneity (P = 0.9899) across
            (A) Asian versus non-Asian countries, (B) different sample sizes, (C) cancer types included in the current analysis, (D) age groups, (E) tumor stages, and
            (F) SIRT1 expression levels.

            lung cancer (n = 3, P = 0.025) and gastric cancer (n = 2,   effect = 1.5, 95% CI [0.752 – 2.244], P ≤ 0.001) and female
            P = 0.025) also showed significant effects with low   (overall effect = 1.46, 95% CI [0.524 – 2.393], P = 0.002)
            heterogeneity (I  = 0.03). In contrast, studies on uterine   cohorts, with no observed heterogeneity (I  = 0.00).
                         2
                                                                                                     2
            cancer (n = 2, P = 0.051) and renal cell carcinoma (n = 2,   Various tumor stages also showed significant prognostic
            P  = 0.061)  showed trends  toward  significance,  with low   value for SIRT1, including stages I–IV (P < 0.001) and I–III
            heterogeneity (I  = 0.05 and I  = 0.06, respectively).   & IV (P = 0.013), with low to no heterogeneity.
                                       2
                         2
            However, studies on breast cancer and colorectal cancer
            did not show statistically significant results (P = 0.136 and   Importantly, the prognostic value of SIRT1 appeared to
            P = 0.221, respectively). The prognostic value of SIRT1 also   vary based on SIRT1 expression levels in a relatively unique
            varied across different age groups. Significant effects were   manner. The analysis revealed that studies (n = 10) reporting
            observed in the age groups 56 – 60 with no heterogeneity   high SIRT1 expression showed highly statistically significant
            (I  = 0.00) and 61 – 65 with low heterogeneity (I  = 0.02).   effects (P < 0.001), with no observed heterogeneity
                                                   2
             2
                                                                2
            However, the age groups 50 – 55 and 66 – 70 did not show   (I  = 0.00%). Conversely, five studies focusing on cancers
            statistically significant results (P = 0.161 and P = 0.237,   with low SIRT1 expression showed statistically significant
                                                                                                             2
            respectively). The prognostic effect of SIRT1 remained   results (P  = 0.011),  with  a low level  of heterogeneity (I
            significant and  consistent  across  both  male (overall   = 0.01%). Overall, the subgroup analyses revealed consistent
            Volume 4 Issue 1 (2025)                         6                               doi: 10.36922/gpd.4294
   109   110   111   112   113   114   115   116   117   118   119